Teen Development
Also known as: Adolescent development
Methodology & AI Transparency ⓘ
Teen Development Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: As a teenager, you go through many physical, mental, emotional, and social changes.
- 2 Real-world patient consensus: Synonyms for Teen Development (F33.3): Adolescent development (Depression & Mood).
- 3 Typical cash cost range: Workup highlights for Teen Development (F33.3): sleep-wake rhythm assessment [Teen Development F33.3].
- 4 Top reported side effects / signs: Objective lab/clinical target for Teen Development: PHQ-9 Symptom Severity in Teen Development (F33.3: Score) (< 4 (clinical remission) (F33.3)) and TSH & Free in Teen Development (F33.3: T4 Rule-Out).
Ask our AI Specialists anything about Teen Development
What Is Teen Development?
As a teenager, you go through many physical, mental, emotional, and social changes. The biggest change is puberty , the process of becoming sexually mature. It usually happens between ages 10 and 14 for girls and ages 12 and 16 for boys. As your body changes, you may have questions about sexual health . During this time, you start to develop your own unique personality and opinions. Some changes that you might notice include: Increased independence from your parents More concerns about body image and clothes More influence from peers Greater ability to sense right and wrong All of these changes can sometimes seem overwhelming. Some sadness or moodiness can be normal.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in depression & mood, Teen Development (F33.3) involves monoaminergic (serotonin [Teen Development F33.3]. Cross-referenced with NIH MeSH (Psychology, Adolescent, Adolescent Development), progression correlates with shifts in PHQ-9 Symptom Severity in Teen Development (F33.3: Score) (< 4 (clinical remission) (F33.3)).
Common Symptoms & Clinical Signs
- • Increased independence from your parents
- • More concerns about body image and clothes
- • Presentation of Teen Development (F33.3): loss of interest in Teen Development (F33.3: or pleasure in)
- • Secondary Teen Development clinical sign: persistent low mood, in Teen Development (F33.3: emotional flatness, or)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Teen Development Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F33.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Depression, Bipolar & Mood Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: PHQ-9 Symptom Severity in Teen Development (F33.3: Score) | < 4 (clinical remission) (F33.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Free in Teen Development (F33.3: T4 Rule-Out) | TSH 0.8 – 2.5 mIU/L (F33.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin D in Teen Development (F33.3: & RBC Folate) | 25(OH)D 40 – 65 ng/mL (F33.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Teen Development
Treatment selection for Teen Development depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Teen Development)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| When Antidepressants Aren't Enough: Can Adding SAMe Help Lift Stubborn Depression? SAMe may provide relief of depression symptoms similar to imipramine or escitalopram. General hospital psychiatry • 2024-01-15 • Meta-Analysis | N = 1,522 | 99/100 | PMID 38199136 ↗ |
| New Insights on Randomized, gold-standard blind comparison of aripiprazole/sertraline combination: What a 412-Participant Study Found In patients with MDD who showed an inadequate response to treatment with sertraline 100 mg/day, ASC was efficacious and well tolerated. Psychiatry and clinical neurosciences • 2018-08-15 • Randomized Controlled Trial | N = 412 | 93/100 | PMID 29660207 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in These novel data support semaglutide 2.4 mg as an efficacious obesity treatment in adolescents with obesity and advance its application by showing associated improvements in insulin sensitivity, glycemic measures, ALT, and... Diabetes care • 2026-06-01 • Phase III Randomized Trial | N = 129 | 88/100 | PMID 41296499 ↗ |
| New Insights on Adjunctive Cariprazine for the Treatment of Patients With depression: A: What a 249-Participant Study Found Adjunctive cariprazine at 1.5 mg/day demonstrated efficacy in reducing depressive symptoms in adults with depression and inadequate response to antidepressants alone. The American journal of psychiatry • 2023-03-01 • Phase III Randomized Trial | N = 249 | 88/100 | PMID 36789515 ↗ |
| Can This Approach Help? Inside the Latest Research on Generalizability of Treatment Outcome Prediction Across Antidepressant Treatment In 363 adult patients (225 from EMBARC and 138 from CANBIND-1; mean [SD] age, 36.6 [13.1] years; 235 women [64.7%]), the best-performing models using pretreatment clinical features and functional connectivity of the dorsal... JAMA network open • 2025-03-03 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 40111362 ↗ |
Teen Development Patient Community & “People Like Me” Threads
Filter Teen Development community threads and patient logs by age, biological sex, dosage, and treatment duration.